Biochemical and Physiological Response to Stressogenic Stimuli

August 29, 2019 updated by: Nadav Goldental

Measuring the Biochemical and Physiological Response to Controlled Stressogenic Stimuli

Post-traumatic stress disorder (PTSD) is characterized by physiological changes, some of which are thought to be chronic, while others are observed in response to stressogenic stimuli. A psychiatric diagnosis of PTSD is currently based mainly on non-quantitative elements, such as interviews and subjective impressions. Discernable patterns of stress-related measures may constitute a physiological and biochemical phenotype characteristic of PTSD, which may serve as a biomarker and support diagnostic decisions, as well as personalized treatment plans.

The current study is aimed at examining the possibility of basing a psychiatric diagnosis by measuring changes in the biochemical phenotype of participants with PTSD. Physiological and biochemical data will be collected from participants with and without PTSD using wearable sensors and adhesive biosensor patches. The data will be collected in two conditions: in a neutral, quiet situation, and during and following exposure to controlled stressogenic stimuli.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • PTSD diagnosis (excluding controls)
  • Proper ability to give informed consent

Exclusion Criteria:

  • Active oncological/cardiovascular condition
  • Dialysis patients
  • Active psychotic or suicidal symptoms
  • Severe dissociative symptoms
  • A traumatic brain injury (TBI) diagnosis
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pariticapnts with PTSD
Participants will be exposed to an anxiety-provoking stimulus for 15-20 minutes, in a controlled setting
Physiological and biochemical measures will be obtained using the Biobeat smart watch and adhesive biosensor patches.
Experimental: Pariticapnts without PTSD (controls)
Participants will be exposed to an anxiety-provoking stimulus for 15-20 minutes, in a controlled setting
Physiological and biochemical measures will be obtained using the Biobeat smart watch and adhesive biosensor patches.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Significant differences between groups - HRV
Time Frame: 3 hours
Significant differences in Heart Rate Variability - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - temperature
Time Frame: 3 hours
Significant differences in physiological changes - body temperature- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - SPO2
Time Frame: 3 hours
Significant differences in physiological changes - Saturation SPO2- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - blood pressure
Time Frame: 3 hours
Significant differences in physiological changes - continuous blood pressure- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - pulse pressure
Time Frame: 3 hours
Significant differences in physiological changes - pulse pressure - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups -respiratory rate
Time Frame: 3 hours
Significant differences in physiological changes - respiratory rate- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups -stroke volume
Time Frame: 3 hours
Significant differences in physiological changes - stroke volume- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups -cardiac output
Time Frame: 3 hours
Significant differences in physiological changes - cardiac output - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - systemic vascular resistance
Time Frame: 3 hours
Significant differences in physiological changes - systemic vascular resistance- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in cortisol levels between groups
Time Frame: 3 hours
Significant differences in biochemical changes - cortisol - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - C-reactive protein
Time Frame: 3 hours
Significant differences in biochemical changes - C-reactive protein - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - Interleukin 6
Time Frame: 3 hours
Significant differences in biochemical changes - Interleukin 6 - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - N-terminal B-type natriuretic peptide
Time Frame: 3 hours
Significant differences in biochemical changes - N-terminal B-type natriuretic peptide - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - 8-oxo-7
Time Frame: 3 hours
Significant differences in biochemical changes - 8-oxo-7- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - 8-dihydro-2'-deoxyguanosine
Time Frame: 3 hours
Significant differences in biochemical changes - 8-dihydro-2'-deoxyguanosine - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - hexanone
Time Frame: 3 hours
Significant differences in biochemical changes - hexanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - acetic acid
Time Frame: 3 hours
Significant differences in biochemical changes - acetic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - heptane
Time Frame: 3 hours
Significant differences in biochemical changes - heptane - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - hexanal
Time Frame: 3 hours
Significant differences in biochemical changes -hexanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - 3-heptanone
Time Frame: 3 hours
Significant differences in biochemical changes - 3-heptanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - hexanoic acid
Time Frame: 3 hours
Significant differences in biochemical changes - hexanoic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - heptanal
Time Frame: 3 hours
Significant differences in biochemical changes -heptanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - nonanal
Time Frame: 3 hours
Significant differences in biochemical changes - nonanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - glucose
Time Frame: 3 hours
Significant differences in biochemical changes - glucose - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2019

Primary Completion (Anticipated)

February 1, 2020

Study Completion (Anticipated)

June 1, 2020

Study Registration Dates

First Submitted

August 22, 2019

First Submitted That Met QC Criteria

August 29, 2019

First Posted (Actual)

September 3, 2019

Study Record Updates

Last Update Posted (Actual)

September 3, 2019

Last Update Submitted That Met QC Criteria

August 29, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Traumatic Stress Disorder

Clinical Trials on Stressogenic stimulus

3
Subscribe